103 related articles for article (PubMed ID: 7607784)
1. Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis.
Calabrese V; Raffaele R; Cosentino E; Rizza V
Int J Clin Pharmacol Res; 1994; 14(4):119-23. PubMed ID: 7607784
[TBL] [Abstract][Full Text] [Related]
2. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
Ghabaee M; Jabedari B; Al-E-Eshagh N; Ghaffarpour M; Asadi F
Int J Neurosci; 2010 Apr; 120(4):301-4. PubMed ID: 20374079
[TBL] [Abstract][Full Text] [Related]
3. [Decreased antioxidant-defence mechanisms in cerebrospinal fluid (CSF) in patients with tick-borne encephalitis (TBE)].
Pancewicz SA; Hermanowska-Szpakowicz T; Makarewicz-Płońska M; Witek A; Farbiszewski R; Zajkowska J; Michalska B
Neurol Neurochir Pol; 2002; 36(4):767-76. PubMed ID: 12418140
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of oxidoreductive potential of patients with neuroborreliosis].
Pancewicz SA; Skrzydlewska E; Hermanowska-Szpakowicz T; Stankiewicz A; Kondrusik M
Przegl Epidemiol; 2002; 56(3):425-33. PubMed ID: 12608092
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in perinatal asphyxia.
Kumar A; Ramakrishna SV; Basu S; Rao GR
Pediatr Neurol; 2008 Mar; 38(3):181-5. PubMed ID: 18279752
[TBL] [Abstract][Full Text] [Related]
6. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I
Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.
Gumral N; Naziroglu M; Ongel K; Beydilli ED; Ozguner F; Sutcu R; Caliskan S; Akkaya A
Cell Biochem Funct; 2009 Jul; 27(5):276-83. PubMed ID: 19475625
[TBL] [Abstract][Full Text] [Related]
8. Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Adamczyk-Sowa M; Sowa P; Pierzchala K; Polaniak R; Labuz-Roszak B
J Physiol Pharmacol; 2012 Dec; 63(6):683-90. PubMed ID: 23388485
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress indicators are elevated in de novo Parkinson's disease patients.
Ilic TV; Jovanovic M; Jovicic A; Tomovic M
Funct Neurol; 1999; 14(3):141-7. PubMed ID: 10568214
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis.
Koruk M; Taysi S; Savas MC; Yilmaz O; Akcay F; Karakok M
Ann Clin Lab Sci; 2004; 34(1):57-62. PubMed ID: 15038668
[TBL] [Abstract][Full Text] [Related]
11. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas.
Li W; Yanoff M; Jian B; He Z
Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):59-66. PubMed ID: 10099840
[TBL] [Abstract][Full Text] [Related]
12. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma.
Fiaschi AI; Cozzolino A; Ruggiero G; Giorgi G
Eur Rev Med Pharmacol Sci; 2005; 9(6):361-7. PubMed ID: 16479741
[TBL] [Abstract][Full Text] [Related]
13. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
Chaudhry J; Ghosh NN; Roy K; Chandra R
Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
[TBL] [Abstract][Full Text] [Related]
14. Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis.
Ahmadpoor P; Eftekhar E; Nourooz-Zadeh J; Servat H; Makhdoomi K; Ghafari A
Iran J Kidney Dis; 2009 Jan; 3(1):22-7. PubMed ID: 19377255
[TBL] [Abstract][Full Text] [Related]
15. Aflatoxin B1 induces apoptosis in rat liver: protective effect of melatonin.
Meki AR; Abdel-Ghaffar SK; El-Gibaly I
Neuro Endocrinol Lett; 2001 Dec; 22(6):417-26. PubMed ID: 11781538
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid nitrite and malondialdehyde levels in patients with motor neuron disease.
Shukla R; Rajani M; Barthwal MK; Srivastava N; Dikshit M
Int J Neurosci; 2003 Aug; 113(8):1043-54. PubMed ID: 12888419
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and antioxidant defenses after prolonged starvation in Dentex dentex liver.
Morales AE; Pérez-Jiménez A; Hidalgo MC; Abellán E; Cardenete G
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):153-61. PubMed ID: 15556078
[TBL] [Abstract][Full Text] [Related]
18. Possibilities to control the health risk of petrochemical workers.
Georgieva T; Michailova A; Panev T; Popov T
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S21-6. PubMed ID: 12397407
[TBL] [Abstract][Full Text] [Related]
19. Increased cerebrospinal fluid and plasma levels of ultraweak chemiluminescence are associated with changes in the thiol pool and lipid-soluble fluorescence in multiple sclerosis: the pathogenic role of oxidative stress.
Calabrese V; Bella R; Testa D; Spadaro F; Scrofani A; Rizza V; Pennisi G
Drugs Exp Clin Res; 1998; 24(3):125-31. PubMed ID: 9825228
[TBL] [Abstract][Full Text] [Related]
20. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid.
Mihailović M; Cvetković M; Ljubić A; Kosanović M; Nedeljković S; Jovanović I; Pesut O
Biol Trace Elem Res; 2000 Jan; 73(1):47-54. PubMed ID: 10949968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
